Professor Gregory Lip

Professor Lip, MD, is Price-Evans Chair of Cardiovascular Medicine, at the University of Liverpool, UK – and Director of the Liverpool Centre for Cardiovascular Science at the University of Liverpool and Liverpool Heart & Chest Hospital. He is also Distinguished Professor at Aalborg University, Denmark; and Adjunct Professor at Seoul National University and Yonsei University, Seoul, Korea. He also holds Visiting or Honorary Professorships in various other Universities in UK, Serbia (Belgrade), China (Beijing, Nanjing, Guangzhou), Thailand (Chiangmai, Mahidol) and Taiwan (Taipei). Half of his time is spent as a clinical cardiologist, including outpatient clinics (leading atrial fibrillation and hypertension specialist services) and acute cardiology. Professor Lip has had a major interest into the epidemiology of atrial fibrillation (AF), as well as the pathophysiology of thromboembolism in this arrhythmia. Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA2DS2-VASc and HAS-BLED scores - for assessing stroke and bleeding risk, respectively – were first proposed and independently validated following his research, and are now incorporated into international guidelines. The ABC (Atrial fibrillation Better Care) pathway proposed by him is the core recommendation in the 2020 European AF guidelines, and has been shown to reduce adverse outcomes in AF patients. In 2014, Professor Lip was ranked by Expertscape as the world's leading expert in the understanding and treatment of AF [http://bit.ly/2apB1Dt], a position still maintained in 2023 (https://bit.ly/3eP3qR4). Professor Lip was on the writing committee for various international guidelines, including chairing the American College of Chest Physicians (ACCP) Antithrombotic Therapy Guidelines for Atrial Fibrillation, as well as various guidelines and/or position statements from the European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), Asia-Pacific Heart Rhythm Society (APHRS) etc. Professor Lip has acted as senior/section editor for major international textbooks and at senior editorial level for major international journals, including Thrombosis & Haemostasis (Editor-in-Chief, Clinical Studies); Europace (Associate Editor); and Circulation (Guest Editor). His current group’s research interests are broad, ranging from epidemiology to pathophysiology, translational research, clinical risk assessment and trajectories of risk, patient management pathways, and applied health research. He is passionate about using ‘big data’ and epidemiological observations to generate hypotheses and to inform clinical studies that help improve the management of common cardiovascular conditions, such as atrial fibrillation, hypertension and thrombosis. This ‘big data’ work is often in collaboration with an extensive global network of friends and collaborators, including those in Denmark, France, the Balkans, Taiwan, Korea and Japan, sharing a common goal in ‘research without boundaries’ in relation to epidemiology and clinical studies. Professor Lip has been conferred a number of honorary doctorate degrees - doctor medicinae honoris causa from Aalborg University, Denmark (http://bit.ly/2fGyIfC) see https://www.youtube.com/watch?v=a9qj1geikPo; University of Medicine & Pharmacy “Carol Davila”, Bucharest, Romania (http://bit.ly/2CVadVP) ; Belgrade University, Serbia; and i'Universite de Tours, France (http://bit.ly/2I3VyeH). Also, in 2020: Medical University of Silesia in Katowice, Poland (Doctor Honoris Causa); and University of Modena, Italy (https://youtu.be/iBkungOafaM).